Clinical Trial Update: A Comprehensive Multiomic Biomarker Evaluation Across Two Single-arm Cohorts to Elucidate Mechanisms of Response and Resistance in Recurrent/Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update describing two single-arm cohorts in recurrent/metastatic head and neck squamous cell carcinoma, focusing on comprehensive multiom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Snippet

Sponsor: University Health Network, Toronto | Conditions: Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma | Phase 2 | Status: NOT_YET_RECRUITING